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Methodology: Thirty patientswere divided, according to the degree of injury severity score (ISS), into
three equal groups: mild, moderate, and severe trauma groups. According to sampling time, samples
from each group were further subdivided, into three subgroups, within the ﬁrst 24 h of admission, on
the third day, and on the ﬁfth day of admission. The level of sICAM-1 was measured in plasma using
the ELISA technique in relation to the time passed since inﬂiction of injury. The control group fol-
lowed the same order of sampling. Many factors were studied in the current study such as sex, nature
of injury, associated severe head injuries, and the combining bone and soft tissue affection.
Results: Asigniﬁcant increasewas noticed in all subgroupswhen comparedwith the control group.A
characteristic pattern of sICAM-1 variationwith the timing ofwoundswas at itsmaximum level on the
third daypost-traumaand thendecreases toward its normal level. This patternwas only affected by the
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Timing of wounding remains an unresolved problem for the
forensic pathologist. Practical experience enables the expert
to estimate the timing of wounds on the basis of macroscopic
examination which is not sufﬁcient in many other cases and
additional more sensitive and speciﬁc markers are required.
In the past 50 years, comprehensive research on this topic
has resulted in a better understanding of the acute inﬂamma-
tory reaction after wound inﬂiction.1 The age of a wound
can be assessed to a certain degree using traditional histologi-
cal methods.2 The development and application of sensitive
and speciﬁc markers through research in the areas of histo-
chemistry, enzymology and biochemistry have provided in a
partial solution to the exact determination of the wound age.1
The dynamics of inﬂammatory cytokines in the healing pro-
cess of wounds have been studied for possible wound age
determination. These experiments indicate that cytokines have
a close relationship to wound remodeling as well as to inﬂam-
mation.3 It has been proved that the detection of an increased
expression of adhesion molecules can improve the wound age
assessment in injuries.4
Intercellular adhesionmolecule type-1 (ICAM-1 or CD54) is
a member of adhesion molecules family. It is a 90-kDA type-1
transmembrane glycoprotein with ﬁve immunoglobulin-like
extracellular domains. ICAM-1 is either a transmembrane pro-
tein (mICAM-1) or soluble (sICAM-1). sICAM-1 has been re-
ported to be present in serum, cerebrospinal ﬂuid, and
bronchoalveolar lavage,5 and its expression is induced by vari-
ous inﬂammatory mediators and inhibited by glucocorticoids.6
It is the most important of a group of related immunoglobulin
superfamily (IgSF) molecules that serve as ligands for the inte-
grin.7 It is expressed basally on the surface of cells in immune re-
sponses mainly the endothelial, epithelial, and ﬁbroblastic cells.
Its main role is to mediate leukocyte migration and adhesion to
target structures by binding to the leukocyte adhesion receptor
(LFA-1).8 In general, elevated levels of sICAM-1 appear to be
associated with inﬂammatory conditions and certain malignan-
cies and its increased expression augments immune responses
and leukocyte accumulation in inﬂamed tissues.9
The aim of the present study is to correlate between the le-
vel of sICAM-1 and the timing of trauma in living individuals.
2. Methodology
Thirty patients of both sexes were studied following trauma.
These patients were admitted to Emergency Department of
Ain Shams University Hospital and Ain Shams Specialized
Hospital in Cairo, Egypt, in addition to six healthy adult per-
sons of both sexes who have not been recently exposed to any
trauma or infection and were used as control group.
All patients admitted to hospital within 6 h of injury were
subjected to a full history taking including, history of present
illness, nature of injury, cause of injury, past medical andmedications history. Also, a physical examination was per-
formed for all the patients to determine site of injury, type
of injury, a full neurological examination. Finally, an assess-
ment of injury severity was carried out by Injury Severity Score
as discussed later. An informed consent was taken from each
patient or responsible family member.
Patients with past medical history of diagnosed chronic
inﬂammatory diseases and malignancies were excluded from
this study. This was performed because ICAM-1 levels were
noticed to be increased in untreated inﬂammatory arthritis,10
in patients with colorectal cancer,11 in basal cell carcinoma,12
in bronchial asthmatics,13 in the acute phase of plasmodium vi-
vax malaria,14 in patients with unstable angina and subendo-
cardial myocardial infarction.15 On the other hand, ICAM-1
levels were noticed to be decreased in severe glucocorticoid-
dependent asthma patients.16
According to Cocks and Chan,17 the patients of the present
study were divided, according to the degree of injury severity
score (ISS), into three groups, group II (mild trauma) with
ISS < 9, group III (moderate trauma) with ISS 9–15, and group
IV (severe trauma) with ISS > 15, each group consisted of ten
patients. Each group is further subdivided, according to sam-
pling time, into three subgroups IIa, IIIa, and IVa (within the ﬁrst
24 h of admission), subgroups IIb, IIIb, and IVb (on the third
day) and subgroups IIc, IIIc, and IVc (on the ﬁfth day of admis-
sion), while the control group (Group I) consisted of six persons.
Venous blood samples were collected, from each patient in
the studied groups, within the ﬁrst 24 h of admission. Another
sample was obtained from each patient on the third and the
ﬁfth days. The control group was sampled once. All the sam-
ples were collected in the early morning, before breakfast
according to Dugue et al.,18 who reported pre-analytical fac-
tors, such as inﬂuence of the time of day, food intake, and
physical and psychological stress on the level of serum
ICAM-1 in humans, and concluded that all of these pre-ana-
lytical factors induced a signiﬁcant increase (approximately
10%) in the concentration of sICAM-1.
These samples were used for estimation of plasma level of
soluble intracellular adhesion molecule type-1 (sICAM-1)
and measured by Enzyme Linked Immunosorbent Assay
(ELISA). The kit was manufactured by R&D systems GmbH,
Borsigstra, 65205 Wiesbaen-Nordenstadt, Germany, and im-
ported to Egypt by Clinilab Company, Maadi, Cairo.
A number of other factors were also compared with the
sICAM-1 level and these included the sex of the studied
individuals, the nature of injury, the associated severe head
injuries, and the combining bone affection with the soft tissue
injuries. These data were statistically analyzed using e.g.
Student’s ‘t’, ANOVA and Pearson’s correlation tests.
3. Results
In the present study, the mean age for both sexes in this study
was 39.03 ± 22.02 years (range 6–80). Eight cases (26.66%)
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from 21 to 40 years; 13 (43.33%) were in age group of 41 years
and above. There were 8 females (26.66%) and 22 males
(73.33%) in the studied group with a female to male ratio
1:2.75. Forty percent of patients were injured due to motor
car accident, 30% due to falling from a height, 16.66% due
to slipping on the ground, and sharp objects were the cause
of injury in 13.33% of all the patients. The mean injury sever-
ity score of all patients was 17.06.
According to gender difference, there was no signiﬁcant dif-
ference between both males and females concerning sICAM-1
level in all subgroups.
The level of sICAM-1 was estimated in relation time passed
since inﬂiction of injury. There was a signiﬁcant increase in
sICAM-1 level in subgroups IIa and IIc and a highly signiﬁ-
cant increase in subgroup IIb when compared with the control
group. Also, there was a signiﬁcant increase in subgroup IIb
(mild trauma on the third day) when compared with subgroup
IIa and a highly signiﬁcant increase in the same subgroup
when compared with subgroup IIc, while there was non signif-
icant difference between subgroup IIa and IIc (Table 1).
Moreover, there was a highly signiﬁcant increase in
sICAM-1 level in all subgroups of the moderate trauma group
(IIIa, IIIb, and IIIc) when compared with the control group.
Also there was a highly signiﬁcant increase in subgroup IIIb
(moderate trauma on the third day) when compared with both
subgroup IIIa and IIIc (Table 2).
In addition, there was a highly signiﬁcant increase in
sICAM-1 level in subgroups of the severe trauma group IVa
and IVb and a signiﬁcant increase in subgroup IVc when com-
pared with the control group. Also there was a signiﬁcant dif-
ference between subgroup IVb (severe trauma on the third
day) and subgroup IVc, while there was no signiﬁcant differ-
ence between subgroup IVa and both subgroups IVb and
IVc (Table 3).
The effect of major head injury on the sICAM-1 level was
studied in the current work on the admission day, the third
and the ﬁfth days in patients’ group having major head injury
and the patients’ group having minimal or no head injury.
There was a signiﬁcant increase in the level of sICAM-1 on
the admission day, the third and the ﬁfth days, in patients’
group having major head injury when compared with those
having minimal or no head injury (Table 4).
The different factors in the present work (the nature of
injury, the associated severe head injuries, and the combining
bone affection with the soft tissue injuries) did not affect the
characteristic pattern of sICAM-1 variation with the timing
of wounds, which was more relevant on the third day post-Table 1 Student’s t-test of soluble intercellular adhesion molecule (sI
subgroups).
Group I n= 6 Subgroup IIa
sICAM-1 level (ng/ml) M 139.6667 203.7244
SD ±44.3269 ±56.4912
t1 and P1 2.36
t2 and P2
t3 and P3
M: mean; t1 and P1: control group vs all subgroups; SD: standard devia
highly signiﬁcant; t3 and P3: subgroup IIb vs subgroup IIc. P< 0.05: sitrauma, while they only affected the level of sICAM-1 accord-
ing to the severity of injury with a directly proportional rela-
tionship, which was clearly evidenced by the highest level of
sICAM-1 in the severely traumatized individuals e.g. the fall-
ing from a height group having the highest ISS, followed by
both ‘car accident’ and ‘slipping on the ground’ groups and
then the ‘sharp object’ group which has the lowest ISS (Table
5).
Furthermore, sICAM-1 level was found to be signiﬁcantly
correlated with the degree of injury severity in the patient
group on the ﬁrst, third, and ﬁfth days. In addition, there
was a highly signiﬁcant increase in sICAM-1 level in the stud-
ied subgroups when compared with the control group and a
highly signiﬁcant difference between the subgroups in the same
day of admission (Table 6).
4. Discussion
In the current work, a signiﬁcant increase was noticed in all
subgroups when compared with the control group. A charac-
teristic pattern of sICAM-1 variation with the timing of
wounds was at its maximum level on the third day post-trauma
and then decreases toward its normal level. This was in accor-
dance with Drebler et al. who reported a strong positive
ICAM-1 staining reaction on endothelial cells and keratino-
cytes observed 1.5 h after injury at the earliest in a study per-
formed on the human skin wounds. The oldest wound with a
strong positive staining reaction was 3.5 days old.2 Also,
Dressler et al. investigated in another study 465 skin wounds.
The samples were taken from human autopsy material, during
the surgical treatment of wounds (excision) of patients and
from experimental incised wounds of mice. Strong positive
staining was observed of ICAM-1 1.5 h at the earliest and
3.5 days at the latest in human skin wounds.4
On the other hand, the results of the current study disagrees
with a study made in London by Giannoudis et al., who stud-
ied 31 patients with a mean injury severity score (ISS) of 14
(range 9–57), in which venous blood samples were collected
within 6 h of injury, and found that sICAM-1 levels raised sig-
niﬁcantly by day 3 following injury and subsequently in-
creased, the magnitude of the increase being related to the
degree of injury.19
The difference between the results published in different
studies between the reported variations in sICAM-1 expression
might lie in the uncertainty of the information concerning the
time of injury as stated by Drebler et al.2 In the current study,
information was obtained from the admission sheets of the pa-
tients or relying on information imparted by the patients them-CAM-1) level in group I, subgroup IIa, IIb, and IIc (mild trauma
n= 10 Subgroup IIb n= 10 Subgroup IIc n= 10
297.839 177.4897
±32.6073 ±24.7109
<0.05 8.23 <0.0001 2.21 <0.05
4.56 <0.05 1.35 >0.05
9.3 <0.0001
tion; t2 and P2: subgroup IIa vs subgroups IIb and IIc. P< 0.0001:
gniﬁcant. P> 0.05: non signiﬁcant.
Table 3 Student’s t-test of soluble intercellular adhesion molecule (sICAM-1) level in group I, subgroup IVa, subgroup IVb, and IVc
(severe trauma groups).
Group I n= 6 Subgroup IVa n= 10 Subgroup IVb n= 10 Subgroup IVc n= 10
sICAM-1 level (ng/ml) M 139.6667 518.5466 628.277 419.6285
SD ±44.3269 ±174.4939 ±134.7527 ±180.5484
t1 and P1 5.15 <0.0001 8.51 <0.0001 3.68 <0.05
t2 and P2 1.57 >0.05 1.25 >0.05
t3 and P3 2.93 <0.05
M: mean; t1 and P1: control group vs all subgroups; SD: standard deviation; t2 and P2: subgroup IVa vs subgroups IVb and IVc. P< 0.0001:
highly signiﬁcant; t3 and P3: subgroup IVb vs subgroup IVc. P< 0.05: signiﬁcant. P> 0.05: non signiﬁcant.
Table 4 Student’s t-test of soluble intercellular adhesion molecule (sICAM-1) level on the admission day, the third and the ﬁfth days
in major head injury group with minimal or no head injury group.
sICAM-1 level (ng/ml) Minor or no head injury n= 7 Major head injury group n= 23
Admission day M 312.98 418.20
SD ±49.10 ±119.00
t P 2.256 <0.05
Third day M 404.89 522.2
SD ±102.00 ±176.2
t P 1.964 <0.05
Fifth day M 246.00 367.87
SD ±106.01 ±124.3
t P 2.33 <0.05
M: mean; SD: standard deviation; t and P: comparison between both groups. P< 0.05: signiﬁcant.
Table 2 Student’s t-test of soluble intercellular adhesion molecule (sICAM-1) level in group I subgroup IIIa, IIIb, and IIIc (moderate
trauma subgroups).
Group I n= 6 Subgroup IIIa n= 10 Subgroup IIIb n= 10 Subgroup IIIc n= 10
sICAM-1 level (ng/ml) M 139.6667 290.035 371.775 225.526
SD ±44.3269 ±27.044 ±47.408 ±18.957
t1 and P1 8.46 <0.0001 9.7 <0.0001 5.44 <0.0001
t2 and P2 4.72 <0.0001 6.12 <0.0001
t3 and P3 9.06 <0.0001
M: mean; t1 and P1: control group vs all subgroups; SD: standard deviation; t2 and P2: subgroup IIIa vs subgroups IIIb and IIIc. P< 0.0001:
highly signiﬁcant; t3 and P3: subgroup IIIb vs subgroup IIIc.
Table 5 ANOVA one way statistical analysis test of soluble intercellular adhesion molecule (sICAM-1) level on the admission day,
the third and ﬁfth days in the patient group with different causes of injury (car accident, falling from a height, slipping on the ground,
and wounding with sharp objects).
sICAM-1 level
(ng/ml)
Car accident
n= 12
Falling from a
height n= 9
Slipping on the
ground n= 5
Sharp objects
n= 4
F P
Admission day M 330.983 388.15 319.59 246.966 3.4033 <0.05
SD ±73.39 ±80.866 ±67.19 ±76.47
Third day M 417.67 481.67 444.11 353.09 3.0115 <0.05
SD ±54.96 ±88.79 ±79.588 ±87.77
Fifth day M 278.06 303.88 260.62 212.87 2.87 <0.05
SD ±44.61 ±64.44 ±54.59 ±43.34
M: mean; SD: standard deviation; F: variance ratio; P< 0.05: signiﬁcant.
90 M.K. Zaki et al.selves. Drebler et al. added that these discrepancies might pos-
sibly also be caused by differences in materials and methods (in
the present study ELISA was used, compared to immunohisto-chemistry and ﬂow cytometry in other studies).2 Moreover,
many of the results given in the literature were obtained in ani-
mal experiments (mouse, rat), although the skin morphology
Table 6 Correlation between the injury severity score (ISS)
and the level of soluble intercellular adhesion molecule Type 1
(sICAM-1) in the patient group on the admission day, on the
third and on the ﬁfth day.
Statistical analysis
Studied parameter r P
sICAM-1 level in the patient group
on the admission day
0.76 <0.0001
sICAM-1 level in the patient group
on the third day
0.751 <0.0001
sICAM-1 level in the patient group
on the ﬁfth day
0.752 <0.0001
r: Pearson’s correlation; P< 0.0001: highly signiﬁcant.
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from those of man.20,21
In the current work, there was a signiﬁcant increase in the
level of sICAM-1 on the admission day, the third and the ﬁfth
days, in patients’ group having major head injury when com-
pared with those having minimal or no head injury. These ﬁnd-
ings are in agreement with those obtained by McKeating
et al.22 who found that serum sICAM-1 was signiﬁcantly re-
lated to neurological outcome and suggests that the inﬂamma-
tory response to injury may be detrimental. Moreover, Polin
et al. detected soluble ICAM-1 in the cerebrospinal ﬂuid of pa-
tients after subarachnoid hemorrhage and it was found that
the level of sICAM-1 was elevated in the CSF of these patients
compared with levels in the CSF of normal controls.23
Balabanov et al. found an increased expression of ICAM-1
2hours post-impact and was sustained through 24 h in a trial
to study endothelial cell activation following moderate trau-
matic brain injury.24
In the current study, there was no signiﬁcant difference in
the level of sICAM-1 between the group having isolated soft
tissue injury and the group having both soft tissue and bone
fracture on the admission day. While, there was a signiﬁcant
increase in the level of sICAM-1 in patients’ group having
combined soft tissue injury and bone fracture when compared
to the isolated soft tissue injury group in both the third and
ﬁfth days post-trauma. This could be attributed to the fact that
the more tissue destruction, the more is the activation of
bound and soluble adhesion molecule and cytokine levels in
cases of severe trauma by experimental injury in rats.25,26
In the current study, causes of injury in relation to the inter-
cellular adhesion molecule-1 (ICAM-1) level were studied. A
signiﬁcant increase in the ‘falling from a height’ group in rela-
tion to the other groups, followed by other groups. This could
be attributed to the highest injury severity score in the ‘falling
from a height’ group with multiple injuries leading to more
cytokines production which play a critical part in the genera-
tion of cellular inﬂammation following trauma, and this will
lead to more sICAM-1 production.
Moreover, a highly signiﬁcant correlation was found be-
tween the degree of injury severity score and the increased level
of the soluble ICAM-1. Also, there was a highly signiﬁcant in-
crease in sICAM-1 level in the studied subgroups when com-
pared with the control group and a highly signiﬁcant
difference between the subgroups in the same day of admis-
sion. This was in agreement with Giannoudis et al.19 whofound a highly signiﬁcant increase in the levels of both
sICAM-1 and sE-selectin at day 5 after trauma, also it was
found that the more severely injured groups have signiﬁcantly
higher levels of both sICAM-1 and sE-selectin. In addition,
sICAM-1 level was found to be signiﬁcantly correlated with
the degree of injury severity and outcome in many other stud-
ies.22,27–295. Conclusion and recommendations
Serum sICAM-1 can be beneﬁcial in the estimation of the
inﬂiction time in traumatized individuals, at least in excluding
some self inﬂicted wounding preceding the allegation time. It is
also an easier method when compared to all previous studies
which were performed using immunohistochemistry by taking
tissue samples from living subjects.
Further studies are needed to be performed on sICAM-1-
level in trauma patients on a wider range of patients of differ-
ent ages and multiplicity of injuries including burns and
electrocution victims, also there is a need to study its level in
cases of posttraumatic multiple organ failure and septic com-
plications which were not accessible in the current work. We
also recommend the use of more variable injury severity scores
in the future studies.
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